Grant: Operating Grant
Sunnybrook Research Institute (Toronto, Ontario)
$130,322.00
Long term outcomes of a multicentre controlled clinical trial of breast irradiation using Intensity-Modulated Radiation Therapy
EF 2010-11
Résumé
Women diagnosed with an early stage cancer of the breast usually have the cancer removed by lumpectomy and then have radiation treatments to the entire breast. The radiation treatments prevent the cancer from growing back in the breast for nearly all women.
In 2008 we have published the result of a canadian multicentre study funded by the CIHR showing that a novel radiation technique called Intensity Modulated Radiation Therapy (IMRT) significantly reduces the occurence of radiation burns in women treated with radiotherapy from 48% to 31%. Intensity Modulated Radiation Therapy (IMRT) is a way to treat the breast so that there are no areas in the breast that receive more radiation than necessary, and so that the skin receives less radiation.
While radiation burns on the skin are associated with pain and a reduction of the quality of life they generally heal few weeks after the treatment. It is possible that more permanent treatment side complications, including the occurence of patch of red vessels under the skin, of indurations or of a chronic pain may be linked to the occurence of radiation burns. If so the novel technique of breast IMRT may also reduce those long term and permanent side effects. We will do scientific measurements to find out if the there is a reduction in permanent complications of the radiation treatment like permanent skin damages when using the novel radiation technique is used. To do so, we will recall all patients treated in tyhe first trial for a single clinical assessment at the Cancer Centre.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
210945
Name
Pignol Jean-Philippe
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Cancer Progression & Therapeutics
Projecttitle
Long term outcomes of a multicentre controlled clinical trial of breast irradiation using Intensity-Modulated Radiation Therapy
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$130,322
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Adjuvant Radiotherapy; Breast Cancer; Delayed Side Effects; Intensity Modulated Radiation Therapy (Imrt); Randomised Control Clinical Trial
Abstract
Women diagnosed with an early stage cancer of the breast usually have the cancer removed by lumpectomy and then have radiation treatments to the entire breast. The radiation treatments prevent the cancer from growing back in the breast for nearly all women.
In 2008 we have published the result of a canadian multicentre study funded by the CIHR showing that a novel radiation technique called Intensity Modulated Radiation Therapy (IMRT) significantly reduces the occurence of radiation burns in women treated with radiotherapy from 48% to 31%. Intensity Modulated Radiation Therapy (IMRT) is a way to treat the breast so that there are no areas in the breast that receive more radiation than necessary, and so that the skin receives less radiation.
While radiation burns on the skin are associated with pain and a reduction of the quality of life they generally heal few weeks after the treatment. It is possible that more permanent treatment side complications, including the occurence of patch of red vessels under the skin, of indurations or of a chronic pain may be linked to the occurence of radiation burns. If so the novel technique of breast IMRT may also reduce those long term and permanent side effects. We will do scientific measurements to find out if the there is a reduction in permanent complications of the radiation treatment like permanent skin damages when using the novel radiation technique is used. To do so, we will recall all patients treated in tyhe first trial for a single clinical assessment at the Cancer Centre.
Competitiondate
201009
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pignol, Jean-Philippe
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $130,322~ $0~